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Endovascular therapy reduces disability and death in patients with large vessel occlusion strokes (LVOS).1–5 
Despite this major therapeutic breakthrough discovery, the 
public health impact of this treatment is highly dependent on 
rapid identification of severe stroke symptoms by emergency 
medical system personnel and transport to a comprehensive 
stroke center with experience providing fast, effective, and 
safe intervention.
Although several clinical examination tools have been pro-
posed for use in the prehospital setting, most of these tools 
have not been validated using arterial contrast imaging to 
determine the presence of LVOS.6,7 Thus, the best prehospital 
strategy for identifying patients with severe stroke symptoms 
remains to be determined.
Considering the limited availability of comprehensive 
stroke centers and the time sensitivity of both intravenous 
tissue-type plasminogen activator and endovascular therapy,8,9 
accurate identification of patients with high probability of 
having an LVOS in the prehospital setting is of paramount 
importance.
To address this problem, we designed this study to improve 
the accuracy of predicting LVOS by using a new tool called the 
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Field Assessment Stroke Triage for Emergency Destination 
(FAST-ED).
Subjects and Methods
The FAST-ED scale (Facial Palsy [scored 0–1], Arm weakness [0–2], 
Speech changes [0–2], Time [documentation for decision making 
but no points], Eye deviation [0–2], and Denial/neglect [0–2]) was 
designed based on items of the National Institutes of Health Stroke 
Scale (NIHSS) with higher predictive value for LVOS. In addition, 
time was included considering its importance in the prehospital deci-
sion algorithm. For the current analysis, the FAST-ED score was 
derived from the NIHSS score assessed by certified research person-
nel at hospital admission and is shown in Table 1.10
The scale was tested on data from 741 consecutive patients 
enrolled in a prospective cohort study at 2 university-based hospi-
tals, the Screening Technology and Outcomes Project in Stroke 
(STOPStroke), in which admission noncontrast computed tomog-
raphy scans and computed tomographic angiography (CTA) were 
obtained in all patients suspected of having ischemic stroke (stroke, 
transient ischemic attack, or stroke mimics) in the first 24 hours of 
symptom onset. Patients were excluded if iodinated contrast agent 
administration was contraindicated (ie, history of contrast agent 
allergy, pregnancy, congestive heart failure, and increased creatinine 
level) or if there was evidence of intracranial hemorrhage on noncon-
trast computed tomography. The STOPStroke study received insti-
tutional review board approval at both participating institutions and 
was Health Insurance Portability and Accountability Act compliant.
For this study, patients with unilateral acute complete symptom-
atic occlusion of the intracranial internal carotid artery (intracranial 
ICA), M1 and M2 segments of the middle cerebral artery (MCA) and 
basilar artery were selected and compared with patients without a 
proximal intracranial occlusion. Patients with symptomatic bilateral 
and anterior+posterior circulation occlusions were excluded from the 
analysis. Our prespecified hypothesis was that the FAST-ED would 
have similar or higher accuracy than other preexisting scales.
Image Protocol and Review
The STOPStroke noncontrast computed tomography and CTA protocol 
is described elsewhere.11 Image review was independently performed 
on a picture archiving and communication system workstation (Impax; 
AGFA Technical Imaging Systems, Richfield Park, NJ) by a board-
certified neuroradiologist and a clinical neurologist experienced in 
stroke imaging interpretation. Disagreements in readings were resolved 
by consensus. Reviewers were blinded to follow-up clinical and imag-
ing findings but had information in regard to the patients’ age, sex, and 
presenting clinical symptoms. Neither of the reviewers had participated 
in the selection of the patients. For every image, vessels were graded 
for the presence or absence of total occlusion according to a 5-point 
level of certainty score (score 5, definitely present; score 4, probably 
present; score 3, equivocal; score 2, probably absent; and score 1, defi-
nitely absent). Those subjects with equivocal scores were excluded from 
the analysis. The site of intracranial occlusion was defined as the most 
proximal site of occlusion (intracranial ICA, MCA-M1, MCA-M2, and 
basilar). Functional outcomes were assessed with the use of the modi-
fied Rankin scale (mRS) at 6 months.
Statistical Analysis
Continuous variables are reported as mean±SD or as median±interquartile 
range (IQR). Categorical variables were reported as proportions.
The Spearman test was used to test the linear correlation of the 
NIHSS and the FAST-ED scores. Receiver operating characteristics 
(ROC) curve analysis was used as the primary analysis to test whether 
the FAST-ED had higher discrimination ability than other similar 
previous published scales (the Rapid Arterial Occlusion Evaluation 
[RACE] Scale, the Cincinnati Prehospital Stroke Severity [CPSS] 
scale, and the NIHSS).12,13 The areas under the curve were compared 
with the FAST-ED as the reference.14 Calibration of FAST-ED was 
assessed graphically and by the use of the Hosmer and Lemeshow 
test.15 Given the potential influence of time to presentation on NIHSS, 
sensitivity analyses were performed including only those patients 
who underwent CTA within 12 hours from symptom onset and again 
in those patients who underwent CTA within 6 hours from symptom 
onset. Partial occlusions on conventional angiography are generally 
classified as total occlusion on CTA.16 However, as some patients 
were still classified as partial occlusion on CTA, we also performed 
a sensitivity analysis including those patients with partial occlusion 
on CTA.
Sensitivity, specificity, positive predictive value, negative pre-
dictive value, and accuracy were calculated using several different 
thresholds of the FAST-ED. The Youden Index was used to evaluate 
the optimal threshold of the FAST-ED scale.17 Prespecified published 
thresholds of the other scales and a cutoff of 6 and 10 points in the 
NIHSS were used for comparison.10,18
The distribution of the FAST-ED was also compared according to 
the mRS at 6 months (dichotomized as good, mRS score of ≤2 and 
poor outcome, mRS score of >2). The Kruskal–Wallis test was used 
to compare the distribution of the FAST-ED scores according to the 
most proximal site of occlusion (intracranial ICA, MCA-M1, MCA-
M2, and basilar). A 2-sided P value of <0.05 was considered sig-
nificant. All statistical analysis was performed using SPSS software 
(version 20.0).
Results
Seven hundred twenty-seven qualifying patients were selected. 
The mean age was 68.1±15.4 years, median baseline NIHSS 
Table 1. The FAST-ED Scale and Its Correspondence to the 
NIHSS
Item FAST-ED Score
NIHSS Score 
Source
Facial palsy
  Normal or minor paralysis 0 0–1
  Partial or complete paralysis 1 2–3
Arm weakness
  No drift 0 0
  Drift or some effort against gravity 1 1–2
  No effort against gravity or no 
movement
2 3–4
Speech changes
  Absent 0 0
  Mild to moderate 1 1
  Severe, global aphasia, or mute 2 2–3
Eye deviation
  Absent 0 0
  Partial 1 1
  Forced deviation 2 2
Denial/Neglect
  Absent 0 0
  Extinction to bilateral simultaneous 
stimulation in only 1 sensory 
modality
1 1
  Does not recognize own hand or 
orients only to one side of the body
2 2
FAST-ED indicates Field Assessment Stroke Triage for Emergency 
Destination; and NIHSS, National Institutes of Health Stroke Scale.
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was 5 (IQR, 2–12), and 52% were males. LVO was detected 
in 240 (33%) subjects. Fifty-three (7.3%) subjects had occlu-
sion of the intracranial ICA, 98 (13.5%) of the MCA-M1, 74 
(10.2%) of the MCA-M2, and 15 (2.1%) of the basilar artery. 
As expected, the FAST-ED had a strong correlation with 
NIHSS (r=0.92; P<0.001).
The FAST-ED scale had comparable accuracy to predict 
LVO to the more complex NIHSS and higher accuracy than 
RACE and CPSS (area under the ROC curve: FAST-ED=0.81 
as reference; NIHSS=0.80, P=0.28; RACE=0.77, P=0.02; 
and CPSS=0.75, P=0.002; Figure 1A). A similar pattern was 
seen when the analysis was repeated for those patients who 
underwent CTA within 12 hours (n=393; area under the ROC 
curve: FAST-ED 0.83 as reference; NIHSS=0.81, P=0.17; 
RACE=0.79, P=0.03; and CPSS=0.769, P=0.001; Figure 1B) 
and within 6 hours from symptom onset (n=360; area under 
the ROC curve: FAST-ED=0.83 as reference; NIHSS=0.81, 
P=0.26; RACE=0.79, P=0.08; and 0.77, P=0.02; Figure 1C).
Ninety-four patients had partial occlusions on CTA. A simi-
lar pattern was observed when those patients were included 
with FAST-ED having a similar area under the curve when 
compared with the NIHSS but larger when compared with 
RACE and CPSS (area under the ROC curve: FAST-ED=0.79 
as reference; NIHSS=0.77, P=0.24; RACE=0.74, P=0.003; 
and CPSS=0.73, P<0.001).
Good calibration of the FAST-ED scale for the prediction of 
LVOS was observed (0–9.3%, 1–14.3%, 2–30.0%, 3–32.9%, 
4–59.2%, 5–69.8%, 6–84.4%, 7–77.4%, 8–83.3%, 9–80.0%, 
and Hosmer and Lemeshow test P value=0.62; Figure 2). An 
important increase in the frequency of LVO was detected for 
those patients with FAST-ED score of ≥4, whereas a FAST-ED 
score of <2 was specifically associated with a low likelihood 
Figure 1. A, Receiver operating characteristic curves comparing the discrimination of Field Assessment Stroke Triage for Emergency Des-
tination (FAST-ED), National Institutes of Health Stroke Scale (NIHSS), Rapid Arterial Occlusion Evaluation (RACE), and Cincinnati Prehos-
pital Stroke Severity (CPSS) scales for the detection of large vessel occlusion strokes (all subjects). B, Subjects who performed computed 
tomographic angiography (CTA) of ≤12 hours from symptom onset. C, Subjects who performed CTA of ≤6 hours from symptom onset. 
AUC indicates area under the curve. All individual curves presented a P value <0.001.
Figure 2. Proportion of patients with large vessel 
occlusion strokes according to the Field Assess-
ment Stroke Triage for Emergency Destination 
(FAST-ED) scale. Hosmer and Lemeshow test: 
0.62.
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of LVO. There was a steady increase in the frequency of poor 
outcome (6-month mRS score of >2) with higher FAST-ED 
scores (0–11.8%, 1–25.7%, 2–41.6%, 3–42.2%, 4–52.4%, 
5–60.3%, 6–85.7%, 7–85.7%, 8%–100%, and 9% to 100%; 
Figure 2).
Better performance of FAST-ED according to the Youden 
Index could be shown at 2 distinct thresholds of ≥3 (Youden 
Index=0.490) and ≥4 (Youden Index=0.491; Table 2). A 
threshold of ≥3 and ≥4 in the FAST-ED for LVO had a sen-
sitivity of 0.71 and 0.60, specificity of 0.78 and 0.89, posi-
tive predictive value of 0.62 and 0.72, and negative predictive 
value of 0.84 and 0.82 versus RACE ≥5, 0.55, 0.87, 0.68, and 
0.79 and CPSS ≥2, 0.56, 0.85, 0.65, and 0.78, NIHSS ≥6 0.76, 
0.70, 0.55, and 0.85 and NIHSS ≥10 0.64, 0.85, 0.68, and 
0.83, respectively (Table 3).
The median NIHSS was 14.5 (IQR, 6.2–19.7), 14 (IQR, 
9.7–17), 8 (IQR, 4–15.5), and 17 (IQR, 14–32) for intracranial 
ICA, MCA-M1, MCA-M2, and basilar occlusion, respectively 
(P=0.003). The median FAST-ED score was 5 (IQR, 2.2–6.7), 
5 (IQR, 3–6), 3 (IQR, 2–5), and 5 (IQR, 1–7) for intracranial 
ICA, MCA-M1, MCA-M2, and basilar occlusion, respectively 
(P<0.001). As previously noted, an important increase in the 
frequency of large vessel occlusion was observed for those 
subjects with FAST-ED score of ≥4 when compared with 
those with the scores of <4. Moreover, the proportion of LVO 
in those subjects with FAST-ED of ≥4 was mostly because of 
an increase in the frequency of more proximal occlusions such 
as MCA-M1 and intracranial ICA occlusions (Figure 3).
Discussion
We found that the FAST-ED has high sensitivity and high 
specificity for the detection of LVOS. It demonstrated a similar 
discrimination capacity when compared with the more com-
plex NIHSS score and higher discrimination when compared 
with other scales. It can identify stroke patients with high like-
lihood of a proximal intracranial occlusion, especially those 
with intracranial ICA and MCA-M1, who are most likely to 
benefit from rapid triage to comprehensive stroke centers that 
are capable of delivering both intravenous tissue-type plas-
minogen activator and endovascular treatment, thus avoiding 
unnecessary and costly delays.
Other scales have also been developed to predict LVOS 
in the prehospital setting and demonstrated good sensitiv-
ity and specificity. The RACE scale has been applied in the 
field and shown to reasonably identify LVOS.13 However, 
the RACE scale was validated in a population where most of 
patients were diagnosed with transcranial Doppler, which is 
less sensitive and specific for the detection of LVOS than CTA 
especially for distal MCA-M1 and M2 occlusion.19 When com-
pared with FAST-ED, RACE gives a higher weight to motor 
symptoms. Specifically, a patient can be assessed 1 extra point 
for facial weakness and ≤2 extra points for leg weakness that 
would not be computed in FAST-ED. Although motor symp-
toms strongly correlated with higher NIHSS scores, they are 
not good discriminators of non-LVOS versus LVOS as they 
may also occur in the setting of subcortical or lacunar strokes. 
Conversely, the RACE scale only computes 1 point for gaze 
deviation (versus ≤2 points in the FAST-ED scale). Gaze devi-
ation is a typical sign of cortical (or brain stem) dysfunction 
and as such is a powerful discriminator of LVOS. Although 
FAST-ED tests both fluency (1 point) and comprehension (1 
point), RACE only tests speech with commands and as such 
may miss the opportunity of diagnosing expressive aphasia, 
which is a highly disabling deficit and a strong discrimina-
tor of LVOS. Finally, the RACE scale restricts the evaluation 
of aphasia for those subjects with right weakness and neglect 
for those with left-sided weakness. As such, RACE ignores 
the fact that some patients may have concomitant neglect and 
aphasia and that some left-handed patients might have right 
hemisphere dominance.
The CPSS scale is a simple scale easily implemented in the 
prehospital setting. However, it fails to recognize the impor-
tance of cortical signs, such as aphasia and particularly neglect, 
which are highly associated with large cortical infarcts. A sen-
sitivity of 56% and 55% for the CPSS and RACE scales seem 
unacceptably low for the detection of LVOS.
The FAST-ED scale has the advantage of providing 3 dis-
tinct groups for the likelihood of LVOS: score 0 to 1, <15%; 
2 to 3, ≈30%; and ≥4, ≈60% or higher. This allows for bet-
ter adjustments in triage process according to stroke sever-
ity/likelihood of LVOS, time from stroke onset, and distances 
Table 2. Sensitivity, Specificity, PPV and NPV, and accuracy 
of the FAST-ED Scale
FAST-ED Sensitivity Specificity PPV NPV Accuracy
Youden 
Index
≥1 0.92 0.37 0.42 0.91 0.55 0.29
≥2 0.83 0.64 0.53 0.89 0.70 0.47
≥3 0.71 0.78 0.62 0.84 0.76 0.49
≥4 0.61 0.89 0.72 0.82 0.79 0.49
≥5 0.48 0.93 0.76 0.78 0.78 0.41
≥6 0.30 0.97 0.82 0.74 0.75 0.27
≥7 0.14 0.98 0.79 0.70 0.70 0.12
≥8 0.04 1.00 0.82 0.68 0.68 0.03
≥9 0.17 1.00 0.80 0.67 0.67 0.17
FAST-ED indicates Field Assessment Stroke Triage for Emergency 
Destination; NPV, negative predictive value; and PPV, positive predictive value.
Table 3. Comparison of Thresholds of the FAST-ED, RACE, 
CPSS, and NIHSS According to Sensitivity, Specificity, PPV and 
NPV, and Accuracy
FAST-ED 
≥3
FAST-ED 
≥4
RACE  
≥5
CPSS  
≥2
NIHSS 
≥6
NIHSS 
≥10
Sensitivity 0.71 0.61 0.55 0.56 0.76 0.64
Specificity 0.78 0.89 0.87 0.85 0.70 0.85
PPV 0.62 0.72 0.68 0.65 0.55 0.68
NPV 0.84 0.82 0.79 0.78 0.85 0.83
Accuracy 0.76 0.79 0.77 0.75 0.72 0.78
CPSS indicates Cincinnati Prehospital Stroke Severity Scale; FAST-ED, Field 
Assessment Stroke Triage for Emergency Destination; NIHSS, National Institutes 
of Health Stroke Scale; NPV, negative predictive value; PPV, positive predictive 
value; and RACE, Rapid Arterial Occlusion Evaluation.
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from primary stroke centers versus endovascular capable cen-
ters. Moreover, when LVOS was present, the distribution of 
the FAST-ED scores varied along with the site of intracranial 
occlusion. Those with scores of <4 had a high prevalence of 
MCA-M2 occlusion when compared with those with scores 
of ≥4 who had a higher proportion of MCA-M1 and intra-
cranial ICA occlusions. Because MCA-M2 occlusions have 
higher rates of recanalization with intravenous tissue-type 
plasminogen activator, a lower threshold should be used to tri-
age patients with scores of <4 to the closest stroke center (eg, 
primary stroke center or comprehensive stroke center).
Our study has limitations. Only a limited number of patients 
with basilar occlusions were included in this study, therefore, 
limiting our ability to draw strong conclusions about the per-
formance of the FAST-ED in this group of patients. FAST-ED 
remains to be validated in an independent cohort of patients 
and, in particular, it still must be prospectively tested among 
emergency medical system personnel. However, we think that 
it will not be difficult to teach emergency medical system 
personnel about FAST-ED because they are already familiar 
with the Cincinnati Stroke Scale (FAST), and we just have 
added 2 items to it. Indeed, the FAST-ED scale is simpler 
than the RACE scale (6 items), which has been validated in 
the prehospital setting.13 We have not compared FAST-ED 
with all existing prehospital scales. We could not compare it 
with LAMS because we did not have data on grip strength. 
Although we think LAMS would probably have an inferior 
performance because it does not include highly discriminat-
ing cortical findings, such as aphasia, neglect, and gaze devia-
tion, it has demonstrated high accuracy to detect LVOS in a 
previous study.20 Similarly, we have not made a comparison 
with the stroke vision, aphasia, neglect (VAN) scale. VAN has 
been demonstrated to perform well when applied by NIHSS 
certified emergency room triage nurses.21 However, the VAN 
scale tests 10 different items and; therefore, it seems to be too 
complex and time consuming to be used by emergency medi-
cal system personnel.
In conclusion, given the time-sensitive nature of both intra-
venous and endovascular reperfusion therapies, fast and accu-
rate triage of patients to hospitals, where these therapies are 
available is vital, to prevent delays in care, optimize outcomes, 
and reduce costs associated with unnecessary transfers. 
FAST-ED is a simple scale that if successfully validated in 
field, it might be useful for medical emergency profession-
als to accurately identify LVOS in the prehospital setting, 
enabling rapid triage of patients to primary versus endovascu-
lar capable stroke centers.
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